Clinical outcomes of MED and iLESSYS® Delta for the treatment of lumbar central spinal stenosis and lateral recess stenosis: A comparison study

腰椎管狭窄症 椎管狭窄
作者
Boyu Wu,Chengjie Xiong,Lin-ying Tan,Dongdong Zhao,Feng Xu,Hui Kang
出处
期刊:Experimental and Therapeutic Medicine [Spandidos Publishing]
卷期号:20 (6): 1-1 被引量:6
标识
DOI:10.3892/etm.2020.9382
摘要

Microendoscopic discectomy (MED) is an established procedure used to treat lumbar central spinal stenosis (LCSS) and lateral recess stenosis (LRS). The Interlaminar Endoscopic Surgical System iLESSYS® Delta approach has been developed from the traditional interlaminar endoscopic technique for the treatment of LCSS and LRS. In the present study, MED was used as a reference to evaluate this newly developed approach. A total of 82 and 52 patients with radicular leg pain and/or neurogenic claudication symptoms were treated by spinal canal decompression using the MED or iLESSYS® Delta approach, respectively. The clinical outcomes of the patients were analyzed using the Modified MacNab's criteria, visual analogue scale (VAS) leg pain score, VAS back pain score and the Oswestry Disability Index (ODI) score. Finally, the effectiveness of the decompression was evaluated on a cross-sectional area of the dural sac (CSAD) at the disc level. The incision length in the iLESSYS® Delta group was significantly decreased compared with the MED group (P<0.05); however, the duration of the operation in the iLESSYS® Delta group was significantly longer compared with the MED group (P<0.05). The VAS score of the back and ODI score in the iLESSYS® Delta group were significantly decreased compared with the MED group at the 1-week follow-up (P<0.0125). The postoperative CSAD was also significantly increased in both groups compared with before the operation (P<0.05); however, there were no significant differences in the postoperative CSAD between the two groups. The good-to-excellent rates of the MED and iLESSYS® Delta approach were 89.0 and 90.4%, respectively, whereas the complication rates of the MED and iLESSYS® Delta system were 3.66 and 3.85% in the two groups, respectively. In conclusion, the iLESSYS® Delta approach was identified to be comparable with the MED approach for treating LCSS and LRS, demonstrating both precise and limited decompression. In addition, the iLESSYS® Delta approach may reduce the short-term back pain and promote faster recovery compared with the MED.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
寒月完成签到,获得积分10
2秒前
2秒前
张德帅完成签到,获得积分10
2秒前
xlz完成签到,获得积分10
2秒前
ppp完成签到,获得积分10
5秒前
dou完成签到 ,获得积分10
6秒前
xlz发布了新的文献求助10
6秒前
lakers发布了新的文献求助10
7秒前
7秒前
wzc发布了新的文献求助10
8秒前
8秒前
脑洞疼应助科研通管家采纳,获得10
8秒前
赘婿应助科研通管家采纳,获得10
8秒前
Owen应助科研通管家采纳,获得10
8秒前
科研通AI2S应助科研通管家采纳,获得10
8秒前
卫大伯完成签到,获得积分10
8秒前
yyulemon完成签到,获得积分10
8秒前
ZYY完成签到,获得积分10
9秒前
蛋妞发布了新的文献求助50
11秒前
宋子虎完成签到 ,获得积分10
12秒前
lakers完成签到,获得积分10
12秒前
13秒前
所所应助偏偏意气用事采纳,获得10
17秒前
可爱的函函应助happy采纳,获得10
17秒前
史萌发布了新的文献求助10
19秒前
21秒前
乐乐应助喵喵酱采纳,获得10
22秒前
陈嘻嘻嘻嘻完成签到,获得积分10
23秒前
Fxqq完成签到,获得积分20
24秒前
suke发布了新的文献求助10
24秒前
25秒前
DDF发布了新的文献求助30
26秒前
28秒前
30秒前
兴奋冬萱发布了新的文献求助10
31秒前
泯珉完成签到,获得积分10
31秒前
情怀应助suke采纳,获得10
32秒前
33秒前
英俊的铭应助277采纳,获得10
34秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6524869
求助须知:如何正确求助?哪些是违规求助? 8318196
关于积分的说明 17801276
捐赠科研通 5626697
什么是DOI,文献DOI怎么找? 2928946
邀请新用户注册赠送积分活动 1905579
关于科研通互助平台的介绍 1765472